Home/Filings/4/0001193125-25-240495
4//SEC Filing

Swisher Daniel N JR 4

Accession 0001193125-25-240495

CIK 0001088856other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 6:31 PM ET

Size

8.2 KB

Accession

0001193125-25-240495

Insider Transaction Report

Form 4
Period: 2025-10-10
Transactions
  • Exercise/Conversion

    Stock option (right to buy)

    2025-10-102,2001,100 total
    Exercise: $14.08Exp: 2028-08-20Common Stock (2,200 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-10$14.08/sh+2,200$30,9762,200 total
  • Sale

    Common Stock

    2025-10-10$87.54/sh2,200$192,5880 total
Footnotes (2)
  • [F1]The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 1, 2024 in effect at the time of this transaction.
  • [F2]Fully exercisable.

Documents

1 file

Issuer

CORCEPT THERAPEUTICS INC

CIK 0001088856

Entity typeother

Related Parties

1
  • filerCIK 0001323113

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 6:31 PM ET
Size
8.2 KB